The first two applications for Union authorisation of biocidal products have recently been submitted to ECHA
ECHA will make technical checking of the two applications – including the receipt of the corresponding fee - before sending them to the evaluating competent authority (eCA) through R4BP 3. The eCA will make sure that the applications are complete and will assess the dossiers within one year before providing the outcome to ECHA’s Biocidal Products Committee.
The opinions of the Biocidal Products Committee are expected to be adopted within a maximum period of six months. The Commission will ultimately take the decision on the authorisation of the biocidal products at the Union level. It is a challenge for all authorities involved to reduce the overall period as much as feasible to prove the validity and benefit of the new authorisation system.
Once a biocidal product is granted a Union authorisation, it can be marketed in all European markets without the need for multiple further authorisation processes in many Member States. When considered successful, it is expected that many more companies will avail of this novel route for the authorisation of biocidal products in the future. A further factor that may influence the number of Union applications is the level of the fees for the two alternative authorisation systems. The EU fee regulation is – in line with the BPR - subject to review by the European Commission over the coming months.
Most read news
Organizations
Other news from the department politics & laws
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.